Success Of New Drug For Huntington's Disease Boosts Prana's Share Price

The price of shares in the Australian-based company Prana Biotechnology Ltd. jumped by about 31% after the announcement that its new drug, PBT2, gave an improvement in cognitive function in patients with Huntington's disease.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news